Search scope:
排序： Display mode:
Lin Li, Yuzheng Wu, Jiabao Wang, Huimin Yan, Jia Lu, Yu Wan, Boli Zhang, Junhua Zhang, Jian Yang, Xiaoying Wang, Min Zhang, Yue Li, Lin Miao, Han Zhang
Engineering 2022, Volume 19, Issue 12, Pages 139-152 doi: 10.1016/j.eng.2021.08.020
Traditional Chinese medicine (TCM) has been successfully applied worldwide in the treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the pharmacological mechanisms underlying this success remain unclear. Hence, the aim of this review is to combine pharmacological assays based on the theory of TCM in order to elucidate the potential signaling pathways, targets, active compounds, and formulas of herbs that are involved in the TCM treatment of COVID-19, which exhibits combatting viral infections, immune regulation, and amelioration of lung injury and fibrosis. Extensive reports on target screening are elucidated using virtual prediction via docking analysis or network pharmacology based on existing data. The results of these reports indicate that an intricate regulatory mechanism is involved in the pathogenesis of COVID-19. Therefore, more pharmacological research on the natural herbs used in TCM should be conducted in order to determine the association between TCM and COVID-19 and account for the observed therapeutic effects of TCM against COVID-19.
Keywords： Traditional Chinese medicine SARS-CoV-2 COVID-19 Antivirus Anti-inflammation Immune regulation
Title Author Date Type Operation
京公网安备 11010502051620号
